文献速递妇科

子宫切除术与子宫肌瘤剔除术治疗症状性子宫肌瘤后短期健康相关生活质量的比较

Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas.
PubMed 文献 · Obstet Gynecol · 2019-01-01

本研究为前瞻性比较效果分析,基于多中心注册数据,比较因症状性子宫肌瘤接受子宫切除术或子宫肌瘤剔除术的女性在术后6-12周的健康相关生活质量。共纳入1295例患者(子宫切除术727例,子宫肌瘤剔除术568例),倾向评分加权后两组生活质量均显著改善,子宫切除术组症状严重程度评分平均低4分(均差-4.6;95%CI -7.0至-2.3),部分亚量表评分有差异。

要点

  • 两种术式术后6-12周健康相关生活质量均显著改善。
  • 倾向评分调整后子宫切除术组症状严重程度评分较肌瘤剔除术组平均低4.6分(95%CI -7.0至-2.3)。
  • 微创子宫切除术与微创肌瘤剔除术在担忧和自我意识亚量表上结果相似。

核心结论

  • 子宫切除术和子宫肌瘤剔除术均与短期随访中健康相关生活质量的显著改善相关,在症状严重程度和某些亚量表上存在小幅但具有统计学意义的差异。

研究设计与样本

  • 前瞻性比较效果分析,基于现有多中心注册数据,纳入2015年11月至2018年6月注册的18-54岁有明确子宫肌瘤并接受子宫切除术或子宫肌瘤剔除术的女性,共1295例(子宫切除术727例,子宫肌瘤剔除术568例),采用倾向评分加权调整混杂因素并按手术途径分层分析。

主要发现

  • 基线时子宫切除术组与子宫肌瘤剔除术组的肌瘤特异性健康相关生活质量分别为44.0±25.4和50.2±25.3(P<.01),症状严重程度分别为60.7±23.6和51.7±24.6(P<.01),通用健康相关生活质量分别为69.3±20.4和73.4±18.9(P<.01),差异显著。
  • 倾向评分调整后基线差异消除,术后6-12周两组健康相关生活质量指标均显著改善,子宫切除术组倾向调整后症状严重程度评分较子宫肌瘤剔除术组平均低4.6分(均差-4.6;95%CI -7.0至-2.3)。
  • 子宫切除术组在担忧和自我意识亚量表上评分优于子宫肌瘤剔除术组,按手术途径分层后微创子宫切除术与微创子宫肌瘤剔除术在这两个亚量表上结果相似。
  • 腹部子宫肌瘤剔除术与腹部子宫切除术在症状严重程度评分上无差异,但子宫肌瘤剔除术组在活动和精力/情绪亚量表上评分更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare short-term health-related quality of life (HRQOL) 6-12 weeks after hysterectomy or myomectomy for the treatment of symptomatic leiomyomas. METHODS: We conducted a prospective comparative effectiveness analysis of data. In an existing multisite registry, we compared 6-12-week postsurgical HRQOL using the disease-specific Uterine Fibroid Symptom Quality of Life and the generic EuroQoL 5-Dimension Health Questionnaire, in women from the ages of 18-54 years with documented leiomyomas undergoing hysterectomy or myomectomy. Propensity score weighting was used to adjust for confounding, and analyses were also stratified by route of surgery. RESULTS: A total of 1,295 patients (727 with hysterectomy and 568 with myomectomy) enrolled from registry initiation in November 2015 until June 2018 met inclusion criteria. At baseline, leiomyoma-specific HRQOL (44.0±25.4 and 50.2±25.3, P<.01), symptom severity (60.7±23.6 and 51.7±24.6, P<.01), and generic HRQOL (69.3±20.4 and. 73.4±18.9, P<.01) were significantly different between the hysterectomy compared with myomectomy groups, respectively. Differences were eliminated by propensity adjustment. Substantial improvement in HRQOL measures were seen in both groups at 6-12 weeks, with the mean propensity-adjusted symptom severity score 4 points lower in hysterectomy patients (mean difference -4.6; 95% CI -7.0 to -2.3), compared with myomectomy patients. Hysterectomy patients had better scores on the concern and self-consciousness subscales compared with myomectomy patients. When stratified by surgical route, these two subscale findings were similar between minimally invasive hysterectomy and minimally invasive myomectomy. Symptom severity scores did not differ after abdominal myomectomy compared with abdominal hysterectomy, but subscale scores on activity and energy/mood were higher with myomectomy. CONCLUSION: Both hysterectomy and myomectomy were associated with substantial improvement in HRQOL at short-term follow-up, with small but statistically significant differences in symptom severity and certain subscales. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02260752.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nicholson WK, Wegienka G, Zhang S, et al. Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas. Obstet Gynecol. 2019. PMID: 31306318. doi:10.1097/AOG.0000000000003354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。